Cytek Biosciences, Inc. (CTKB) News
Follow Cytek Biosciences, Inc. (CTKB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Cytek Biosciences Q3 Revenue $53.229 Million
EQUITY | Nov 04, 2026, 09:13 PM UTC
M
Cytek Biosciences to Report Third-Quarter Results November 4
Cytek Biosciences said it will report third-quarter 2026 financial results on November 4, 2026.
EQUITY | Oct 21, 2026, 09:33 PM UTC
L
Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data AnalysisCytek® Cloud digital ecosystemFREMONT, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosci
NEWS | Sep 23, 2026, 09:02 PM UTC
L
CTKB - Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
CTKB - Cytek® Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
NEWS | Sep 23, 2026, 09:00 PM UTC
L
CTKB - Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
CTKB - Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
EQUITY | Sep 09, 2026, 12:31 PM UTC
L
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular insights, greater efficiency, and more streamlined approaches to cell analysis, spectral flow cytometry leader Cytek Biosc
EQUITY | Sep 03, 2026, 09:07 PM UTC
L
CTKB - Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS - Click For Releas
CTKB - Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
EQUITY | Sep 03, 2026, 09:00 PM UTC
L
Cytek Biosciences to participate in upcoming investor conferences
Cytek Biosciences (CTKB) announced it will participate in upcoming investor conferences, with a live and archived webcast available for an included event.
EQUITY | Sep 01, 2026, 08:07 PM UTC
L
CTKB - Cytek Biosciences to Participate in Upcoming Investor Conferences
CTKB - Cytek Biosciences to Participate in Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 08:05 PM UTC
M
Cytek wins jury finding on three of four asserted claims
Cytek says a jury found in its favor on three of four asserted claims, and the company will challenge the remaining finding.
REGULATION | Aug 21, 2026, 08:35 PM UTC
L
Cytek Biosciences Raises FY2026 Sales Guidance from $205.000M-$212.000M to $207.000M-$212.000M vs $208.767M Est
Cytek Biosciences (NASDAQ: CTKB ) raises FY2026 sales outlook from $205.000 million-$212.000 million to $207.000 million-$212.000 million vs $208.767 million estimate.
EARNINGS | Aug 05, 2026, 08:06 PM UTC